David B. Matchar is the Professor of Medicine at Duke University and Inaugural Director of the Program in Health Services and Systems Research at the Duke-National University of Singapore Graduate Medical School.
For nearly 30 years, Professor Matchar has worked in academic clinical policy analysis and development, and clinical practice improvement. He focuses his research on the evaluation of clinical practice based on “best evidence,” and the implementation and evaluation of innovative strategies to promote practice change. He has worked in a wide range of clinical content areas, including cerebrovascular disease, women’s health issues, renal disease, Alzheimer’s disease, multiple sclerosis, migraine, and antithrombotic strategies.
His methodological work addresses the design of effectiveness studies, strategies for bridging the gap between analysts and policy makers, utilizing models to promote communication regarding complex clinical policy questions, and application of decision support systems to link evidence and community practice. He has been the principal investigator of the Stroke Prevention Patient Outcomes Research Team (PORT), a comprehensive seven-year project to evaluate the state of the science in stroke prevention and to implement strategies for practice improvement. He was also the principal investigator for a trial of anticoagulation services in managed care organizations, the Managing Anticoagulation Services Trial (MAST). Currently, he is principal investigator of a four-year implementation trial for practice improvement, the 28-city VA cooperative study #481, The Home International Normalized Ratio Study (THINRS).
In August 2009, Professor Matchar was awarded the prestigious STaR Investigator Award by the Singapore Ministry of Health's National Medical Research Council (NMRC) to establish a system modeling laboratory to evaluate clinical and public policy issues related to aging and disability in Singapore.